Geptanolimab Antibody
Geptanolimab (CBT-501) is a humanized anti-PD-1 IgG4κ monoclonal antibody that reactivates T-cells by blocking PD-L1/2 interactions. It is being investigated in clinical trials for treating cancers such as peripheral T-cell lymphoma and has demonstrated activity in both preclinical in vitro and in vivo studies.
Product Specifications
Product Name Alternative
GB-226, Genolimzumab, APL501, APL-501, CBT501, CBT-501
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
5.18 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.14 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3825103 1.0 µg DNA
Kcnj5 sgRNA CRISPR Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details